Literature DB >> 11243545

Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome.

K R Reddy1, S Kligerman, J Levi, A Livingstone, E Molina, D Franceschi, S Badalamenti, L Jeffers, A Tzakis, E R Schiff.   

Abstract

From 1983 through 1997, our center diagnosed 130 cases of benign neoplasms: 27 with focal nodular hyperplasia (FNH), 25 with hepatic adenoma, 71 with cavernous hemangioma, and seven with mixed tumors of different diagnoses. Most often these lesions were seen in females [female-to-male ratio (f/m): 5.5/1]. Hepatic adenomas and mixed tumors were seen exclusively in females and FNH predominantly in females (f/m: 26/1). Hemangiomas, however, were not uncommon in men (f/m: 52/19) relative to the other tumors (P < 0.001). Furthermore patients with hemangioma were older (mean age: 49 years) whereas patients with hepatic adenoma, FNH, and mixed tumors were often younger (mean age: 33, 35, and 44 years respectively; P < 0.004). Oral contraceptive steroid use was related by 21 of 25 patients (84%) with hepatic adenoma, 22 of 26 (85%) females with FNH, five of seven (71%) females with mixed tumors, and 10 of 52 (19%) patients with hemangioma. Ninety-five of the 130 patients (73%) had one or more symptoms. There was no statistically significant correlation between symptoms and the size of the lesion, the final diagnosis, and whether there were solitary or multiple masses. Three of 25 (12%) with hepatic adenoma presented with rupture, and one of 27 (4%) with FNH had such a consequence. None of the hemangiomas presented with rupture or progressed to such a state. One patient with hepatic adenoma (4%) had a focus of malignancy. Surgical removal of benign tumors was performed in 82 of 130 patients (63%), and there was one operative mortality (1.2%) in a patient who had a caudate lobe FNH. The types of surgical procedures included segmentectomy (62%), lobectomy (34%), and trisegmentectomy (4%). In two of 84 patients who had undergone laparotomy resection was not technically possible. Resection is recommended in all cases of hepatic adenoma because of fear of rupture or associated focus of malignancy. FNH was not observed to undergo a malignant transformation and will rarely rupture. Surgery is only recommended for symptomatic hemangioma, and size of the lesion is not a criterion for excision.

Entities:  

Mesh:

Year:  2001        PMID: 11243545

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  44 in total

Review 1.  Focal nodular hyperplasia--a review of myths and truths.

Authors:  Christopher B Nahm; Kevin Ng; Philip Lockie; Jaswinder S Samra; Thomas J Hugh
Journal:  J Gastrointest Surg       Date:  2011-09-30       Impact factor: 3.452

Review 2.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

3.  Oestrogen hormone receptors in focal nodular hyperplasia.

Authors:  Manju D Chandrasegaram; Ali Shah; John W Chen; Andrew Ruszkiewicz; David S Astill; Georgina England; Ravish S Raju; Eu Ling Neo; Paul M Dolan; Chuan Ping Tan; Mark Brooke-Smith; Tom Wilson; Robert T A Padbury; Christopher S Worthley
Journal:  HPB (Oxford)       Date:  2015-02-28       Impact factor: 3.647

Review 4.  Evaluation of nonmalignant liver masses.

Authors:  Wojciech Blonski; K Rajender Reddy
Journal:  Curr Gastroenterol Rep       Date:  2006-02

5.  Malignant transformation of hepatic adenoma with recurrence after resection.

Authors:  Kenneth A Larson; Sharon M Weber; Yuman Fong; Leslie H Blumgart
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

6.  Hepatic focal nodular hyperplasia: when a benign lesion becomes "malignant". Report of a case.

Authors:  V Papanikolaou; D Vrochides; P Margari; D Giakoustidis; N Antoniadis; K Tsinoglou; E Akriviadis; D Takoudas
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

7.  Painful hepatic hemangioma: report of a case with an emphasis on sonographic findings.

Authors:  Ryusuke Kato; Hideaki Ishida; Hitoshi Yagisawa; Toru Ishii; Tomoya Komatsuda; Takaharu Miyauchi; Tsutomu Sato; Ken Saito
Journal:  J Med Ultrason (2001)       Date:  2009-10-28       Impact factor: 1.314

8.  National trends in the use of surgery for benign hepatic tumors in the United States.

Authors:  Yuhree Kim; Neda Amini; Jin He; Georgios A Margonis; Matthew Weiss; Christopher L Wolfgang; Martin Makary; Kenzo Hirose; Gaya Spolverato; Timothy M Pawlik
Journal:  Surgery       Date:  2015-03-11       Impact factor: 3.982

Review 9.  A case of hepatocellular carcinoma arising within large focal nodular hyperplasia with review of the literature.

Authors:  Theodoros Petsas; Athanassios Tsamandas; Irene Tsota; Dionisios Karavias; Chrysoula Karatza; Vassilios Vassiliou; Dimitrios Kardamakis
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

Review 10.  Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions.

Authors:  Ahmed Ba-Ssalamah; Martin Uffmann; Sanjai Saini; Nina Bastati; Christian Herold; Wolfgang Schima
Journal:  Eur Radiol       Date:  2008-09-23       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.